This link will take you to a website where the Privacy Policy and Cookie Policy of this website do not apply. We are therefore not responsible for your interactions with that website.
This section of the site contains information
for healthcare professionals only.
The user therefore declares that they are a healthcare practitioner and are aware that, in the event of false declaration, the sanctions stipulated in the Criminal Code and the special laws on the falsification of documents shall apply to them, in accordance with Article 76 of Presidential Decree No 445 of 28.12.2000.
To access this section of the site, click YES
if you are a healthcare professional, or NO to exit
Sinovial® 32 – 2 ml
1,6% 32 mg/2 ml
Sinovial® 50 – 2,5 ml
2,0% 50 mg/2,5 ml
Sinovial® is a substitute for synovial fluid, which restores the physiological and rheological properties of arthritic joints.
The hyaluronic acid contained in Sinovial® is obtained by fermentation and is not chemically modified, with excellent tolerability.
Sinovial® is indicated in cases of pain or reduced mobility due to degenerative or post-traumatic diseases or disorders of the joints and tendons.
By restoring the viscoelastic properties of the synovial fluid, Sinovial® relieves pain and restores mobility in the joints and tendons.
Sinovial® acts only at the level of the joint into which it is injected, without exercising any systemic action.
IBSA specialises in research and development,
production and marketing of hyaluronic acid-based products.